Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 30 Carcinoma, Hepatocellular 13 Rectal Neoplasms 5 Sarcoma, Ewing 4 Osteosarcoma 4 Gastrointestinal Stromal Tumors 4 Colonic Neoplasms 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Neoplasm Metastasis 3 Glioblastoma 3 Sarcoma 2 Neoplasms 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Esophageal Neoplasms 2 Chondrosarcoma 2 Bone Neoplasms 2 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Spinocerebellar Degenerations 1 Solid Malignant Tumors 1 Small Cell Lung Carcinoma 1 Recurrence 1 Piebaldism 1 Patient Compliance 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1

Interventions

Fluorouracil 9 Oxaliplatin 7 Leucovorin 7 Surveys and Questionnaires 6 Blood Specimen Collection 6 Bevacizumab 6 Specimen Handling 5 Gemcitabine 5 Cetuximab 5 Capecitabine 5 fludarabine 4 aldesleukin 4 Standard of Care 4 Irinotecan 4 Cyclophosphamide 4 Remote Patient Monitoring 3 Radiosurgery 3 Pafolacianine 3 Nivolumab 3 Endoscopic Mucosal Resection 3 Cisplatin 3 130-nm albumin-bound paclitaxel 3 encorafenib 2 Tomography, X-Ray Computed 2 Sunitinib 2 Referral and Consultation 2 Radiotherapy 2 Practice Guidelines as Topic 2 Pemetrexed 2 Magnetic Resonance Spectroscopy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Gastrointestinal Neoplasms × regorafenib × 1 year × Clear all

NCT02386397 2026-03-12

BREGO

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 1/2 Completed

Gastrointestinal

Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡